Gul M. Khan - Publications

Corrigendum to "Enhancement in site-specific delivery of carvacrol for potential treatment of infected wounds using infection responsive nanoparticles loaded into dissolving microneedles: A proof of concept study." [Eur. J. Pharm. Biopharm. 147 (2020) 57-68].

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: November 18, 2025

Synthesis and evaluation of drug-loaded silver nanoparticles as hemostatic agents to halt uncontrolled bleeding.

Journal: Drug development and industrial pharmacy

Published: December 06, 2024

Evaluation of health-related quality of life of female students suffering from primary dysmenorrhea: findings of a cross-sectional study from Pakistan.

Journal: Frontiers in public health

Published: July 19, 2024

Formulation and Preparation of Losartan-Potassium-Loaded Controlled-Release Matrices Using Ethocel Grade 10 to Establish a Correlation between In Vitro and In Vivo Results.

Journal: Pharmaceutics

Published: December 19, 2023

Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective.

Journal: Journal of nanobiotechnology

Published: October 04, 2023

Impact of pharmacist-led educational services in promoting breast cancer awareness.

Journal: BMC women's health

Published: September 18, 2023

Metformin HCl-loaded transethosomal gel; development, characterization, and antidiabetic potential evaluation in the diabetes-induced rat model.

Journal: Drug delivery

Published: August 31, 2023

Retraction Note: Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout.

Journal: BMC pharmacology & toxicology

Published: July 12, 2023

Corrigendum to 'Mannosylated imiquimod-terbinafine co-loaded transethosomes for cutaneous leishmaniasis; assessment of its anti-leishmanial potential, in vivo safety and immune response modulation' [Biomater. Adv. 145 (2023) 213266].

Journal: Biomaterials advances

Published: March 02, 2023

Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis.

Journal: Drug delivery

Published: February 01, 2023

Triple-combination therapy for cutaneous leishmaniasis using detergent-free, hyaluronate-coated elastic nanovesicles.

Journal: Nanomedicine (London, England)

Published: October 27, 2022

Nitazoxanide and quercetin co-loaded nanotransfersomal gel for topical treatment of cutaneous leishmaniasis with macrophage targeting and enhanced anti-leishmanial effect.

Journal: Heliyon

Published: October 12, 2022